[{"indications": "Indications\u00a0prevention of atherothrombotic events in peripheral arterial disease,\r\nor within 35 days of myocardial infarction, or within 6 months of\r\nischaemic stroke; prevention of artherothrombotic events in acute\r\ncoronary syndrome without ST-segment elevation (given with aspirin\u2014see\r\nnotes above) and in acute myocardial infarction with ST-segment elevation\r\n(given with aspirin\u2014see notes above); prevention of atherothrombotic\r\nand thromboembolic events in patients with atrial fibrillation (given\r\nwith aspirin\u2014\n(From 2.9 Antiplatelet drugs: British National Formulary)\n2.9 Antiplatelet drugs) and for whom warfarin is unsuitable", "name": "CLOPIDOGREL", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "2 Cardiovascular system", "2.9 Antiplatelet drugs", "CLOPIDOGREL"], "cautions": "Cautions\u00a0patients at risk of increased bleeding from trauma, surgery, or other pathological conditions; concomitant use of drugs that increase risk of bleeding; discontinue 7 days before elective surgery if antiplatelet\r\neffect not desirable; interactions: Appendix 1 (clopidogrel)", "side-effects": "Side-effects\u00a0dyspepsia, abdominal pain, diarrhoea; bleeding\r\ndisorders (including gastro-intestinal and intracranial); less commonly nausea, vomiting, gastritis, flatulence, constipation,\r\ngastric and duodenal ulcers, headache, dizziness, paraesthesia, leucopenia,\r\ndecreased platelets (very rarely severe thrombocytopenia), eosinophilia,\r\nrash, and pruritus; rarely vertigo; very\r\nrarely colitis, pancreatitis, hepatitis, acute liver failure,\r\nvasculitis, confusion, hallucinations, taste disturbance, stomatitis,\r\nbronchospasm, interstitial pneumonitis, blood disorders (including\r\nthrombocytopenic purpura, agranulocytosis and pancytopenia), and hypersensitivity-like\r\nreactions (including fever, glomerulonephritis, arthralgia, Stevens-Johnson\r\nsyndrome, toxic epidermal necrolysis, lichen planus)", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/74105.htm", "doses": ["Prevention of atherothrombotic events in peripheral arterial\r\ndisease or after myocardial infarction or ischaemic stroke, 75\u00a0mg\r\nonce daily", "Acute coronary syndrome (without ST-segment elevation), initially\r\n300\u00a0mg then 75\u00a0mg daily (with aspirin\u2014see notes above)", "Acute myocardial infarction (with ST-segment elevation), initially\r\n300\u00a0mg then 75\u00a0mg daily (with aspirin\u2014see notes above); initial dose omitted if patient\r\nover 75 years", "Prevention of atherothrombotic and thromboembolic events in\r\npatients with atrial fibrillation (with aspirin\u2014see notes above), 75\u00a0mg once daily"], "pregnancy": "Pregnancy\u00a0manufacturer advises avoid\u2014no information available"}]